Lunde Ngoc Nguyen, Haugen Mads Haugland, Bodin Larsen Kristina Broe, Damgaard Ingrid, Pettersen Solveig J, Kasem Roya, Rut Wioletta, Drag Marcin, Poreba Marcin, Johansen Harald Thidemann, Solberg Rigmor
Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.
Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Biochimie. 2017 Aug;139:27-37. doi: 10.1016/j.biochi.2017.05.009. Epub 2017 May 17.
The asparaginyl endopeptidase legumain and its inhibitor cystatin E/M are endogenously glycosylated. However, little is known about the nature of the carbohydrate groups and whether they affect the functions of these proteins. In this study both glycosylated and unglycosylated forms of legumain and cystatin E/M were studied. HEK293 cell lines stably over-expressing legumain or cystatin E/M, and HCT116 cells were used as cell models, and mature legumain was purified from bovine kidneys. To obtain unglycosylated proteins, cells were treated with tunicamycin, an inhibitor of N-linked glycosylation, whereas PNGase F and Endo H were used to characterize the glycosylation types. Cells were incubated with glycosylated, unglycosylated proteins and/or legumain selective activity-based probe, and legumain and/or cystatin E/M was studied by activity measurement, ELISA or immunoblotting in cell lysates or conditioned media. Legumain and probe in whole cells were studied by immunofluorescence. The carbohydrates on legumain were shown to be of the hybrid or high mannose type, whereas cystatin E/M was characterized as complex mannose-linked. While glycosylated prolegumain was able to autoactivate, the unglycosylated form was not, and addition of glycosaminoglycans did not facilitate autoactivation of unglycosylated prolegumain. Glycosylated prolegumain was internalized and processed to the mature active form, but no internalization of unglycosylated prolegumain was observed. A Cy5-labelled legumain specific activity-based probe (MP-L09) was synthesized and shown to be a novel tool to study intracellular legumain. Also, internalization of mature legumain (36 kDa) was visualized both alone and complexed with probe. Contrary to the importance of legumain glycosylation, both glycosylated and unglycosylated cystatin E/M showed similar capacity to inhibit legumain. In conclusion, glycosylation of prolegumain is necessary for correct processing to active forms and internalization, whereas the inhibitory property of cystatin E/M is independent of the glycosylation status.
天冬酰胺内肽酶豆球蛋白及其抑制剂胱抑素E/M是内源性糖基化的。然而,关于碳水化合物基团的性质以及它们是否影响这些蛋白质的功能,人们所知甚少。在本研究中,对糖基化和非糖基化形式的豆球蛋白和胱抑素E/M进行了研究。稳定过表达豆球蛋白或胱抑素E/M的HEK293细胞系以及HCT116细胞被用作细胞模型,成熟的豆球蛋白从牛肾中纯化得到。为了获得非糖基化蛋白,细胞用衣霉素(一种N-连接糖基化抑制剂)处理,而PNGase F和内切糖苷酶H用于表征糖基化类型。细胞与糖基化、非糖基化蛋白和/或基于豆球蛋白选择性活性的探针一起孵育,通过活性测量、ELISA或免疫印迹在细胞裂解物或条件培养基中研究豆球蛋白和/或胱抑素E/M。通过免疫荧光研究全细胞中的豆球蛋白和探针。结果表明,豆球蛋白上的碳水化合物为杂合型或高甘露糖型,而胱抑素E/M的特征为复杂的甘露糖连接型。虽然糖基化的前豆球蛋白能够自动激活,但非糖基化形式则不能,添加糖胺聚糖也不能促进非糖基化前豆球蛋白的自动激活。糖基化的前豆球蛋白被内化并加工成成熟的活性形式,但未观察到非糖基化前豆球蛋白的内化。合成了一种Cy5标记的基于豆球蛋白特异性活性的探针(MP-L09),并证明它是研究细胞内豆球蛋白的一种新工具。此外,单独的成熟豆球蛋白(36 kDa)以及与探针复合的成熟豆球蛋白的内化都可以可视化。与豆球蛋白糖基化的重要性相反,糖基化和非糖基化的胱抑素E/M表现出相似的抑制豆球蛋白的能力。总之,前豆球蛋白的糖基化对于正确加工成活性形式和内化是必要的,而胱抑素E/M的抑制特性与糖基化状态无关。